National Reye's Syndrome Foundation
Executive Summary
Requests that FDA-mandated labeling for products containing aspirin be extended to all salicylate-containing products. "Too many cases of Reye's Syndrome have suspiciously been linked to one product in particular, [Procter & Gamble's] Pepto-Bismol, to account for it being coincidental," Chicago Chapter President Carolyn Jender maintained in a recent letter to FDA. The foundation believes that 20%-25% of Reye's Syndrome reported cases are the result of salicylate-containing products.
You may also be interested in...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: